Topical imiquimod for molluscum contagiosum in T cell immunodeficiency [1]

Pediatric Infectious Disease Journal

Volumn 22, Issue 6, 2003, Pages 575-576

  Yazdani, Shahram ^a,c   Stiehm, E Richard ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c General Pediatrics Faculty Group   (United States)

Author keywords

Imiquimod; Immunodeficiency; Molluscum contagiosum

Indexed keywords

IMIQUIMOD;

ADOLESCENT; CASE REPORT; CELLULAR IMMUNITY; CHILD; COMBINED IMMUNODEFICIENCY; COMORBIDITY; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MOLLUSCUM CONTAGIOSUM; PRIORITY JOURNAL;

EID: 0038539691     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000072265.15277.32     Document Type: Letter

References (6)

1. Stiehm ER, Roberts LR, Hanley-Lopez J, et al. Bone marrow transplantation in severe combined immunodeficiency from a sibling who had received a paternal bone marrow transplant. N Engl J Med 1996;335:1811-14.
2. Kline RM, Stiehm ER, Cowan MJ. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation. Bone Marrow Transplant 1996;17:543-8.
3. Sidky YA, Borden EC, Weeks CE, Reiter MJ, Hutcher JF, Bryan GT. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. Cancer Res 1992;52:3528-33.
4. Borden EC, Sidky YA, Weeks CE. Mechanisms of anti-tumor action of the interferon inducer R-837. Proc Am Assoc Cancer Res 1991;32:258.
5. Gibson SJ, Imbertson LM, Wagner TL, et al. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res 1995;15:537-45.
6. Suzuki H, Wang B, Amerio P, et al. Imiquimod, a novel topical immune response modifier, induces migration of Langerhans' cells. J Invest Dermatol 2000;114:135-41.